InvestorsHub Logo
icon url

cngreen

08/05/10 11:05 AM

#6354 RE: Ida Ho #6353

I have to disagree with you there. Buy saying nyloxin was dreamed up because cobroxin failed is incorrect because Nyloxin was mentioned last year when cobroxin was just rolling out. Nyloxin Rx or ES was always supposed to be a stronger version of cobroxin served up by doctors n the USA. Ex: Tylenol and extra strength Tylenol. Nyloxin was also always supposed to be the name of cobroxin outside the USA.
IMO nutrapharma went with another distributor for nyloxin
because xcho did not have the contacts for outside the USA and nphc didn't want to put all their eggs in 1basket. It's diversification 101.

GLTA
icon url

podes

08/05/10 11:38 AM

#6355 RE: Ida Ho #6353

Ida, your post makes no sense to me. If am using Cobroxin and it controls my pain, why would I want to pay more for the same result? I don't get it.

You say "if product A will take away your pain but product B will do twice as good". What is pain free times two?

This fizzling you and nanawisdom (raphael on yahoo board) speak of at this time, does not exsist. We will know more in 6 months. As long as sales increase quarter over quarter, that is what we are looking for.


We just stepped up to plate, no strikes yet.







icon url

stayfocused

08/05/10 11:50 AM

#6356 RE: Ida Ho #6353

Maybe you haven't seen the Ibox or the news over the last 9 months, Cobroxin is in the largest medical retailers, the top 2 of which have 14,000 outlets between them and as far as your question as to why anyone would buy Cobroxin when they could buy Nyloxin extra strength, it's really very simple, cost. Why pay for Nyloxin ES for 25 bucks when Cobroxin (which does the job for most stage 2 chronic pain) can be purchased for below $20. IMO you are overeacting to non existant 'concerns'.


"Cobroxin and XCHO had its chance to step up to the plate and while I will admit that they have not yet struck out . . . the count is 0 - 2"
icon url

Stu-Mc

08/05/10 4:32 PM

#6359 RE: Ida Ho #6353

For all my pharma sofa warriors, yes the two products Cobroxin and Nyloxin will take some market share from each other but they will in essence EXPAND the market because they will A) take more shelf space increasing brand awareness of cobra venom drugs (good thing) B) Increase store sales- can i hear a yeah baby? C) People individualize their need for meds, the key is take what you need, not more than you need, the two product offerrings help different people D) NO product works for everyone except air and even how you take a medicine matters E) Advertising- Gotta create brand awareness and it sounds like we are in the beginning stages F) I am sitting on my investment and dont care about the day to day and if you have more in a stock than you can afford to lose you better think twice (ie you lose sleep at night over what the stock price does on any given day). Everything in my humble opinion, I am accumulating.